Skip to main content

Thermo Fisher Scientific Value Stock - Dividend - Research Selection

Thermo fisher scientific

ISIN: US8835561023 , WKN: 857209

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More

2026-03-27
Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, and, as we mentioned before, it all depends on the status of the war with Iran and the price of oil on any given day. Those two items have dictated the direction of stocks, bonds, precious metals, and crypto since ... Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More

What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release

2026-03-27
Thermo Fisher Scientific will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

Assessing Thermo Fisher Scientific (TMO) Valuation After SHL Medical Alliance And U.S. Capacity Expansion

2026-03-27
Thermo Fisher Scientific (TMO) has drawn fresh attention after agreeing to a collaboration with SHL Medical and committing new investment to its Ridgefield, New Jersey facility, creating an integrated U.S. hub for drug device combination products. See our latest analysis for Thermo Fisher Scientific. Despite the recent collaboration news and the completed Clario acquisition, Thermo Fisher Scientific’s share price is US$488.85, with a 7 day share price return of 4.0%, a year to date share...

Patterson Announces Chief Digital Officer

2026-03-26
ST. PAUL, Minn., March 26, 2026--Patterson Companies has announced the appointment of Gregg Kunes as Patterson’s new chief digital officer. Kunes brings a wealth of experience in driving growth and modernization in complex global distribution and manufacturing environments.

Is Thermo Fisher Scientific (TMO) One of the Best Conservative Stocks to Buy Right Now?

2026-03-26
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Conservative Stocks to Buy Right Now. On March 24, the company announced that it had completed the acquisition of Clario Holdings, Inc. The consideration included $8.875 billion in cash, along with potential additional earnout as well as other payments. These are mainly dependent on performance. […]

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2025 Update

2026-03-25
Viking Global’s Q4 2025 13F: portfolio fell to $37.68B; new stakes in GOOGL/AMZN and exits like META/NFLX.

Thermo Fisher Scientific acquires Clario for nearly $8.9bn

2026-03-25
Clario will become part of Thermo Fisher’s laboratory products and biopharma services segment.

Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions

2026-03-25
RIDGEFIELD, N.J., March 25, 2026--Thermo Fisher Scientific Inc., the world leader in serving science, today announced a strategic collaboration with SHL Medical, a leading provider of advanced drug delivery systems, alongside an expansion of sterile fill-finish and autoinjector final assembly capacity at its Ridgefield, NJ site. Together, these investments establish a fully integrated U.S.-based offering spanning sterile manufacturing, device assembly and commercial packaging for drug-device com

Thermo Fisher completes $8.9B buyout of Clario

2026-03-25
Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.

Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial

2026-03-24
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 2, 2026, AIM ImmunoTech announced entering into an agreement with the PPD clinical research business of Thermo Fisher Scientific (TMO) to design a pivotal Phase 3 clinical trial for Ampligen. The study will […]